LIM-only protein FHL3 interacts with CDC25B2 phosphatase

Experimental Cell Research

Volumn 285, Issue 1, 2003, Pages 99-106

  Mils, Valérie ^a   Lee, Simon Ming Yuen ^b   Joly, Willy ^a   Hang, Eric Wong Chi ^b   Baldin, Véronique ^a   Waye, Mary Miu Yee ^b   Ducommun, Bernard ^a   Tsui, Stephen Kwok Wing ^b  

^a Université de Toulouse Paul Sabatier   (France)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CDC25B; Cell cycle; LIM only protein

Indexed keywords

ISOENZYME; LIM PROTEIN; PROTEIN FHL3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL FATE; CELL LINE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME ASSAY; GENE DELETION; HUMAN; HUMAN CELL; METAPHASE; MOUSE; MYOBLAST; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0345701513     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00018-1     Document Type: Article

References (23)

1. Gabrielli B.G., Clarck J.M., McCormack A., Ellem K.A.O. Hyperphosphorylation of the N-terminal domain of cdc25 regulates activity toward cyclinB1/cdc2 but not cyclin A/cdk2. J. Biol. Chem. 272:1997;28607-28614.
2. Jinno S., Suto K., Nagata A., Igashari M., Kanaoka Y., Nojima H., Okayama H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1994;1549-1556.
3. Garner-Hamrick P.A., Fisher C. Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects. Int. J. Cancer. 76:(5):1998;720-728.
4. Lammer C., Wagerer S., Saffrich R., Mertens D., Ansorge W., Hoffman I. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J. Cell Sci. 111:1998;2445-2453.
5. Gabrielli B.G., De Souza C.P.C., Tonks I.D., Clarck J.M., Hatward N.K., Ellem K.A.O. Cytoplasmic accumulation of CDC25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci. 109:1996;1081-1093.
6. Baldin V., Cans C., Superti-Furga G., Ducommun B. Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene. 14:1997;2485-2495.
7. Forrest A.R., McCormack A.K., DeSouza C.P., Sinnamon J.M., Tonks I.D., Hayward N.K., Ellem K.A., Gabrielli B.G. Multiple splicing variants of cdc25B regulate G2/M progression. Biochem. Biophys. Res. Commun. 260:(2):1999;510-515.
8. Gabrielli B.G., Clark J.M., McCormack A.K., Ellem K.A. Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene. 15:(7):1997;749-758.
9. Davezac N., Baldin V., Gabrielli B., Forrest A., Theis-Febvre N., Yashida M., Ducommun B. Regulation of CDC25B phosphatases subcellular localization. Oncogene. 19:(18):2000;2179-2185.
10. Morgan M.J., Madgwick A.J. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle. Biochem. Biophys. Res. Commun. 255:(2):1999;245-250.
11. Bach I. The LIM domain regulation by association . Mech. Dev. 91:(1-2):2000;5-17.
12. Schmeichel K.L., Beckerle M.C. Molecular dissection of a LIM domain. Mol. Biol. Cell. 8:(2):1997;219-230.
13. Chan K.K., Tsui S.K., Lee S.M., Luk S.C., Liew C.C., Fung K.P., Waye M.M., Lee C.Y. Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene. 210:(2):1998;345-350.
14. Chu P.H., Bardwell W.M., Gu Y., Ross J. Jr., Chen J. FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell Biol. 20:(20):2000;7460-7462.
15. Morgan M.J., Madgwick A.J. Slim defines a novel family of LIM-proteins expressed in skeletal muscle. Biochem. Biophys. Res. Commun. 225:(2):1996;632-638.
16. Chu P.H., Ruiz-Lozano P., Zhou Q., Cai C., Chen J. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech. Dev. 95:(1-2):2000;259-265.
17. Li H.Y., Ng E.K., Lee S.M., Kotaka M., Tsui S.K., Lee C.Y., Fung K.P., Waye M.M. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET). J. Cell. Biochem. 80:(3):2001;293-303.
18. Geiger B., Bershadsky A., Pankov R., Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2:(11):2001;793-805.
19. Turner C.E. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2:(12):2000;E231-236.
20. Wixler V., Geerts D., Laplantine E., Westhoff D., Smyth N., Aumailley M., Sonnenberg A., Paulsson M. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J. Biol. Chem. 275:(43):2000;33669-33678.
21. Chan K.K., Tsui S.K., Ngai S.M., Lee S.M., Kotaka M., Waye M.M., Lee C.Y., Fung K.P. Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47. J. Cell. Biochem. 76:(3):2000;499-508.
22. Rice R., Rusnak J.M., Yokokawa F., Yokokawa S., Messner D.J., Boynton A.L., Wipf P., Lazo J.S. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Biochemistry. 36:(50):1997;15965-15974.
23. Theis-Fabvre N., Filhol-Cochet O., Froment C., Cazales M., Monsarrat B., Ducommun B., Baldwin V. Protein kinase CK2 regulates CDC25B phosphate activity. Oncogene. 22:2003;220-232.